Daily Dose: Blood Pressure Control Declined during Early Months of Pandemic
Your daily dose of clinical news you may have missed.
Wearable Device Uptake Low Among Adults with Cardiovascular Disease, Nationally Representative Study Finds
AHA 2022: An estimated 18% of Americans with heart disease reported using wearables, compared with 29% of the total US population.
RSV Older Adult Vaccine Candidate from GSK Wins FDA Priority Review, PDUFA Date Set
The FDA accepted the GSK BLA and granted priority review to what could be the first vaccine approved against RSV in adults aged ≥60 years, according to the company.
Maternal RSV Vaccine Prevents Infection in Infants, Pfizer Announces
Topline phase 3 trial data showed 81.8% efficacy for the maternal vaccine against severe RSV-related illness in infants from birth through first 90 days of life.
Tirzepatide Associated with More Weight Loss than Placebo Regardless of Obesity-related Comorbidities, New Research Finds
ObesityWeek 2022: Regardless of the number of obesity-related comorbidities, tirzepatide was associated with a greater reduction in body weight than placebo.
Early Months of COVID-19 Associated with Worsening BP Outcomes in Adults with Hypertension, New Study Finds
Use of telemedicine and home blood pressure monitoring may mitigate adverse impact on BP control during future large-scale emergencies, noted researchers.
Daily Dose: Black Adults with Afib Less Likely to Receive Oral Anticoagulation at Hospital Discharge
Investigational Glucagon Receptor/GLP-1 Receptor Dual Agonist Bests Semaglutide for Weight Loss in T2D Patients
ObesityWeek® 2022. Coagonism of the glucagon and GLP-1 receptors appears to result in greater weight loss than GLP-1 receptor agonism alone, study suggests.
Low Uptake of Antiobesity Medications Explored in Patient Perception Survey
ObesityWeek® 2022. Low awareness of antiobesity medications and concerns about cost, side effects revealed as barriers to wider uptake in a new study.
Tirzepatide Led to Clinically Meaningful Improvements in Body Composition in Adults with Obesity/Overweight
ObesityWeek 2022: Tirzepatide-induced weight reduction was associated with body composition improvements in adults with obesity/overweight, found analysis of SURMOUNT-1.
Daily Dose: Low-carb Diet May Help Improve Untreated HbA1c
Black Patients with Afib Significantly Less Likely to Receive Oral Anticoagulation at Hospital Discharge
Black patients were also at significantly increased risk of stroke, bleeding, and mortality vs White patients 1 year following discharge.
New AGA Guidelines Recommend Use of Antiobesity Medications for Weight Management
Adults with obesity who have an inadequate response to lifestyle interventions alone should be offered 1 of 4 suggested medications.
From One Primary Care Physician to Another: Thank You
A small-town physician offers words of encouragement to his peers.
Daily Dose: Finerenone and Heart Failure Outcomes
Adult RSV Vaxx Gets EMA Nod: Can USA be Far Behind?
The GSK RSV vaccine candidate has received favorable international regulatory attention which may be an auspicious sign for the US.
Breast Cancer Rehab and Primary Care, with PM&R Specialist Sean Smith, MD
Breast cancer survivors rely on their primary care clinicians as resources integral to their recovery and return to optimal function. Physiatrist Sean Smith, MD, offers details.
Alcohol Use in America: By the Numbers
Which states have the most binge drinkers? Or the most alcohol-related deaths? A recent analysis provides answers.
Finerenone Mitigates HF, CV Risk Across Baseline Renal Function in Patients with T2D
The findings underscore the importance of routine eGFR and UACR screening in primary care to ensure early detection of CKD and avoid related adverse outcomes.
Low-carbohydrate Diet Could Help Improve Untreated HbA1c of 6.0% to 6.9%
In patients with prediabetes and untreated type 2 diabetes, a reduced carbohydrate diet improved HbA1c and other metabolic markers vs a usual diet.